Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ISRCTN13257145) titled 'Mineralised drinking water to improve diabetes and high blood pressure control in Bangladesh' on Dec. 22, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Open (masking not used) Control: Placebo Assignment: Single Purpose: Treatment

Primary Sponsor: Aquanimity Bangladesh Ltd

Condition: 1. Aged 30-60 years 2. Diagnosed with uncontrolled or poorly controlled type 2 diabetes (HbA1c >8.0%, or fasting plasma glucose =10 mmol/L, or 2-hour post-breakfast glucose =12 mmol/L) 3. Diagnosed with uncontrolled hypertension (SBP >140 mmHg or DBP >90 mmHg) 4. On stable oral ant...